{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:47:00Z","timestamp":1791085620616,"version":"4.1.0"},"reference-count":19,"publisher":"BMJ","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart"],"published-print":{"date-parts":[[1995,6,1]]},"DOI":"10.1136\/hrt.73.6.527","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T21:46:00Z","timestamp":1190151960000},"page":"527-533","source":"Crossref","is-referenced-by-count":224,"title":["Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment."],"prefix":"10.1136","volume":"73","author":[{"given":"G. Y.","family":"Lip","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. D.","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rumley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. G.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","reference":[{"key":"ref_1","first-page":"1050","article-title":"Haemostatic function and cardiovascular death: early results of a prospective study","volume":"i:","author":"Meade, T.W.; North, W.R.S.; Chakrabarti, R.; Stirling, Y.; Haines, A.P.; Thompson, S.G.","year":"1980","unstructured":"Meade TW, North WRS, Chakrabarti R, Stirling Y, Haines AP, Thompson SG. Haemostatic function and cardiovascular death: early results of a prospective study. Lancet 1980;i: 1050-4.","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM198408233110804","article-title":"Fibrinogen as a risk factor for stroke and myocardial infarction","volume":"311","author":"L, Tibblin G.","year":"1984","unstructured":"Wihelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984; 311:501-5.","journal-title":"N Engl J Med"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"956","DOI":"10.7326\/0003-4819-118-12-199306150-00008","article-title":"Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature","volume":"118","author":"Ernst, E.; Resch, K.L.","year":"1993","unstructured":"Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med 1993;118:956-63.","journal-title":"Ann Intern Med"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1161\/01.STR.14.4.511","article-title":"Platelet function tests in thrombotic cerebrovascular disorders","volume":"14","author":"Uchiyama, S.; Takeuchi, M.; Osawa, M.; Kobayashi, I.; Maruyama, S.; Aosaki, M.","year":"1983","unstructured":"Uchiyama S, Takeuchi M, Osawa M, Kobayashi I, Maruyama S, Aosaki M, et al. Platelet function tests in thrombotic cerebrovascular disorders. Stroke 1983;14: 511-7.","journal-title":"Stroke"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0021-9150(93)90157-P","article-title":"Smoking, haemostatic factors and lipid peroxides in a population case control study of peripheral arterial disease","volume":"102","author":"Smith, F.B.; Lowe, G.D.O.; Fowkes, F.G.; Rumley, A.; Rumley, A.G.; Donnan, P.T.","year":"1993","unstructured":"Smith FB, Lowe GDO, Fowkes FG, Rumley A, Rumley AG, Donnan PT, et al. Smoking, haemostatic factors and lipid peroxides in a population case control study of peripheral arterial disease. Atherosclerosis 1993;102: 155-62.","journal-title":"Atherosclerosis"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0140-6736(93)91288-W","article-title":"Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease","volume":"342","author":"Fowkes, F.G.R.; Lowe, G.D.O.; Housley, E.; Rattray, A.; Rumley, A.; Elton, R.A.","year":"1993","unstructured":"Fowkes FGR, Lowe GDO, Housley E, Rattray A, Rumley A, Elton RA, et al. Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease. Lancet 1993;342:84-6.","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1365-2141.1985.tb07476.x","article-title":"Serum crosslinked fibrin (XDP) and fibrinogen\/fibrin degradation products (FDP) in disorders associated with activation of the coagulation or fibrinolytic systems","volume":"60","author":"Hunt, F.A.; Rylatt, D.B.; Hart, R.A.; Bundesen, P.G.","year":"1985","unstructured":"Hunt FA, Rylatt DB, Hart RA, Bundesen PG. Serum crosslinked fibrin (XDP) and fibrinogen\/fibrin degradation products (FDP) in disorders associated with activation of the coagulation or fibrinolytic systems. Br J Haematol 1985;60:715-22.","journal-title":"Br J Haematol"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1161\/01.STR.21.1.47","article-title":"Coagulation factors and the increased risk of stroke in nonvalvular atrial fibrillation","volume":"21","author":"Gustafsson, C.; Blomback, M.; Britton, M.; Hamsten, A.; Svensson, J.","year":"1990","unstructured":"Gustafsson C, Blomback M, Britton M, Hamsten A, Svensson J. Coagulation factors and the increased risk of stroke in nonvalvular atrial fibrillation. Stroke 1990; 21:47-51.","journal-title":"Stroke"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0735-1097(90)90589-H","article-title":"Increased intracardiovascular clotting in patients with chronic atrial fibrillation","volume":"16","author":"Kumagai, K.; Fukunami, M.; Ohmori, M.; Kitabatake, A.; Kamada, T.; Hoki, N.","year":"1990","unstructured":"Kumagai K, Fukunami M, Ohmori M, Kitabatake A, Kamada T, Hoki N. Increased intracardiovascular clotting in patients with chronic atrial fibrillation. J Am Coll Cardiol 1990;16:377-80.","journal-title":"J Am Coll Cardiol"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1136\/bmj.305.6867.1445","article-title":"Antithrombotic treatment and atrial fibrillation","volume":"305","author":"Lowe, G.D.O.","year":"1992","unstructured":"Lowe GDO. Antithrombotic treatment and atrial fibrillation. BMJ 1992;305:1445-6.","journal-title":"BMJ"},{"key":"ref_11","first-page":"535","article-title":"Epidemiology of haematocrit, white cell count, red cell aggregation and fibrinogen: the Glasgow MONICA study","volume":"12","author":"Lowe, G.D.O.; Lee, A.J.; Rumley, A.; Smith, W.C.S.; Tunstall-Pedoe, H.","year":"1992","unstructured":"Lowe GDO, Lee AJ, Rumley A, Smith WCS, Tunstall-Pedoe H. Epidemiology of haematocrit, white cell count, red cell aggregation and fibrinogen: the Glasgow MONICA study. Clin Hemorheol 1992;12:535-44.","journal-title":"Clin Hemorheol"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1161\/01.CIR.82.3.792","article-title":"Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study","volume":"82","author":"Sanfilippo, A.J.; Abascal, V.M.; Sheehan, M.; Oertel, L.B.; Harrigan, P.; Hughes, R.A.","year":"1990","unstructured":"Sanfilippo AJ, Abascal VM, Sheehan M, Oertel LB, Harrigan P, Hughes RA, et al. Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study. Circulation 1990;82:792-7.","journal-title":"Circulation"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/01.CIR.58.6.1072","article-title":"Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements","volume":"58","author":"Sahn, D.J.; DeMaria, A.; Kisslo, J.; Weyman, A.","year":"1978","unstructured":"Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation 1978;58:1072-83.","journal-title":"Circulation"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/hrt.66.5.351","article-title":"Johnson 0. von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death","volume":"66","author":"Jansson, J.H.; Nilsson, T.K.","year":"1991","unstructured":"Jansson JH, Nilsson TK, Johnson 0. von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br Heart J 1991;66: 351-5.","journal-title":"Br Heart J"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1055\/s-0038-1656361","article-title":"A six year prospective study of fibrinogen and other risk factors associated with mortality in stable claudicants","volume":"68","author":"Baneree, A.K.; Pearson, J.; Gilliland, E.L.; Goss, D.; Lewis, J.D.; Stirling, Y.","year":"1992","unstructured":"Baneree AK, Pearson J, Gilliland EL, Goss D, Lewis JD, Stirling Y, et al. A six year prospective study of fibrinogen and other risk factors associated with mortality in stable claudicants. Thromb Haemost 1992;68:261-3.","journal-title":"Thromb Haemost"},{"key":"ref_16","first-page":"1530","article-title":"Regulation of fibrinogen synthesis by plasmin-derived fragments of fibrinogen and fibrin: an","volume-title":"indirect feedback pathway. Proc NatlAcadSci USA","volume":"79","author":"Ritchie, D.G.; Levy, B.A.; Adams, M.A.; Fuller, G.M.","year":"1982","unstructured":"Ritchie DG, Levy BA, Adams MA, Fuller GM. Regulation of fibrinogen synthesis by plasmin-derived fragments of fibrinogen and fibrin: an indirect feedback pathway. Proc NatlAcadSci USA 1982;79:1530-4."},{"key":"ref_17","first-page":"219","article-title":"Gesammelte abhandlungen zur wissenschaftlichen medtzin","author":"Virchow, R.","unstructured":"Virchow R. Gesammelte abhandlungen zur wissenschaftlichen medtzin. Frankfurt: Medinger Sohn, 1856:219-732."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1056\/NEJM199304083281415","article-title":"A hypercoagulable state in the left atrium of patients with mitral stenosis","volume":"328","author":"Yamamoto, K.; Ikeda, U.; Shimada, K.","year":"1993","unstructured":"Yamamoto K, Ikeda U, Shimada K. A hypercoagulable state in the left atrium of patients with mitral stenosis. N EnglJ7 Med 1993;328: 1043-4.","journal-title":"N EnglJ7 Med"},{"key":"ref_19","first-page":"1376","article-title":"Warfarin in chronic atrial fibrillation","volume":"341","author":"Ramsay, L.E.","year":"1993","unstructured":"Ramsay LE. Warfarin in chronic atrial fibrillation. Lancet 1993;341: 1376-7.","journal-title":"Lancet"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/hrt.73.6.527","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T01:07:54Z","timestamp":1601082474000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/hrt.73.6.527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,6,1]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1995,6,1]]}},"URL":"https:\/\/doi.org\/10.1136\/hrt.73.6.527","relation":{},"ISSN":["1355-6037"],"issn-type":[{"value":"1355-6037","type":"print"}],"subject":[],"published":{"date-parts":[[1995,6,1]]}}}